Who owns NEUROGENE INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Neurogene with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Neurogene stock

Who bought or sold NEUROGENE INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
EcoR1 Capital 1.3M $25M 100% Dec 2023
 View chart
Samsara BioCapital 1.3M $25M 100% Dec 2023
 View chart
Dr. Jeffrey R. Jay, M.D. 994k $19M 100% Dec 2023
 View chart
Redmile Group 947k $18M 100% Dec 2023
 View chart
Henderson Group 842k $16M 100% Dec 2023
 View chart
Cormorant Asset Management 746k $15M 100% Dec 2023
 View chart
Arrowpoint Asset Management 526k $10M 100% Dec 2023
 View chart
Casdin Capital 525k $10M 100% Dec 2023
 View chart
Avidity Partners Management 466k $9.0M 100% Dec 2023
 View chart
Baker Bros. Advisors 454k $8.8M 100% Dec 2023
 View chart
Walleye Trading Advisors 189k $3.7M 100% Dec 2023
 View chart
Nantahala Capital Management 72k $1.4M 100% Dec 2023
 View chart
Vanguard Group 50k $977k 100% Dec 2023
 View chart
Bank of America Corporation 50k $964k 100% Dec 2023
 View chart
Bessemer 20k $388k 100% Dec 2023
 View chart
ADAR1 Capital Management 5.4k $105k 100% Dec 2023
 View chart
Us Bancorp 3.5k $67k 100% Dec 2023
 View chart
UBS Group 1.0k $19k 100% Dec 2023
 View chart
Wells Fargo & Company 414.00 $8.0k 100% Dec 2023
 View chart
Royal Bank of Canada 104.00 $2.0k 100% Dec 2023
 View chart
Farther Finance Advisors 50.00 $969.000000 100% Dec 2023
 View chart
Advisor Group Holdings 25.00 $485.000000 100% Dec 2023
 View chart
Jpmorgan Chase & Co 10.00 $194.000000 100% Dec 2023
 View chart
National Bank Of Canada /fi/ 8.00 $158.000000 100% Dec 2023
 View chart

Who sold out of Neurogene?

Fund or Company Name Date Sold Shares Held Valued At
BML Capital Management Dec 2023 25k $478k